Willingdon Wealth Management’s Labcorp LH Stock Holding History

Willingdon Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.4M	Sell	12,856 -904	-7%	-$130K	0.35%	70
2019 Q4	$2M	Sell	13,760 -153	-1%	-$22.1K	0.41%	75
2019 Q3	$2.01M	Sell	13,913 -233	-2%	-$34K	0.44%	74
2019 Q2	$2.1M	Buy	14,146 +242	+2%	+$33.8K	0.49%	71
2019 Q1	$1.83M	Buy	13,904 +384	+3%	+$47.3K	0.45%	76
2018 Q4	$1.47M	Buy	13,520 +13,345	+7,626%	+$1.79M	0.42%	84
2018 Q3	$26K	Hold	175	–	–	0.01%	248
2018 Q2	$27K	Hold	175	–	–	0.01%	224
2018 Q1	$24K	Hold	175	–	–	0.01%	207
2017 Q4	$24K	Buy	+175	New	+$23.1K	0.01%	187

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Willingdon Wealth Management's LH Position: Q1 2020 in Review

Willingdon Wealth Management reduced its Labcorp (LH) stake by 6.6% in Q1 2020, selling an estimated $130K and leaving 12,856 shares worth $1.4M. The position accounts for 0.35% of the portfolio, ranked #70.

Willingdon Wealth Management first reported a position in LH in Q4 2017 and has held it in 10 quarters since. The position peaked at $2.1M in Q2 2019. 759 funds tracked by Wall St. Rank hold LH as of Q1 2020.

Willingdon Wealth Management held 12,856 shares of Labcorp worth $1.4M as of Q1 2020.
Willingdon Wealth Management sold 904 Labcorp shares in Q1 2020, an estimated $130K.
Labcorp made up 0.35% of Willingdon Wealth Management's portfolio in Q1 2020, its #70 holding.
Willingdon Wealth Management first reported a position in Labcorp in Q4 2017 and has held it in 10 quarters since.
Willingdon Wealth Management's Labcorp position peaked at $2.1M in Q2 2019.
759 funds tracked by Wall St. Rank held Labcorp as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.